Abstract: The present invention provides contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin followed by a period of administration of estrogen. The disclosed contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
Type:
Grant
Filed:
July 16, 2004
Date of Patent:
December 21, 2010
Assignee:
Teva Women's Health, Inc.
Inventors:
Robert G. Bell, Carole S. Ben-Maimon, Beata Iskold, Lance J. Bronnenkant, Howard Hait, Kathleen Z. Reape
Abstract: The present invention relates to methods of determining the immunogenic potential of a test product by comparing the immunogenic profile or fingerprint of the test product to the immunogenic profile or fingerprint of a reference product.
Abstract: A dispenser including a first dispensing portion including one group of storage units for each of ten to twenty-eight days, and a second dispensing portion, including at least one storage unit for each of seventeen to thirty days. In the first dispensing portion, a first set includes a group of four storage units for each day, a second set includes a group of three storage units for each day, and a third set includes a group of two storage units for each day. The first dispensing portion contain a progestin. In the second dispensing portion, the first fourteen storage units contain a placebo and the remaining storage units contain a progestin. First and second dispensing portions may be provided as separate dispensing packs, or as a multi-pack of second dispensing portions. The dispenser is useful for treatment of acute episodes of dysfunctional uterine bleeding (DUB) and maintenance treatment for preventing future episodes of DUB.
Abstract: The present invention provides extended cycle contraceptive regimens in which a female is administered a combined dosage form of estrogen and progestin. The disclosed extended cycle contraceptive regimens can be administered to a female as a method of providing non-contraceptive benefits.
Type:
Grant
Filed:
May 3, 2004
Date of Patent:
August 10, 2010
Assignee:
Teva Women's Health, Inc.
Inventors:
Carole S. Ben-Maimon, Howard Hait, Kathleen Z. Reape, Lance J. Bronnenkant